Castleman's disease: A report of two cases at a tertiary hospital in Northern Tanzania

被引:0
作者
Mremi, Alex [1 ,2 ]
Ndale, Eliasa [2 ,3 ]
Stephen, Leonard [3 ]
Mkwizu, Elifuraha [2 ,3 ]
Kilonzo, Kajiru [2 ,3 ]
机构
[1] Kilimanjaro Christian Med Ctr, Dept Pathol, Box 3010, Moshi 255, Tanzania
[2] Kilimanjaro Christian Med Univ Coll, Fac Med, Moshi, Tanzania
[3] Kilimanjaro Christian Med Ctr, Dept Internal Med, Moshi, Tanzania
来源
SAGE OPEN MEDICAL CASE REPORTS | 2023年 / 11卷
关键词
Castleman's disease; case report; Tanzania; INFECTED PATIENTS;
D O I
10.1177/2050313X231175720
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Castleman's disease is a rare lympho-proliferative disease entity characterized by variable clinical presentations, distinctive histological manifestations, and prognosis. Its incidence and etiology are unclear. An interplay of HIV and human herpesvirus-8 has been implicated. Although its localized variety is benign, other types can be multifocal with adverse systemic manifestations. Human herpesvirus-8 Castleman's disease affects mainly HIV-positive individuals; however, individuals who are immunocompromised from other causes can also be affected, thus necessitating investigations for HIV. Herein, we report two patients presenting with long-standing lymphadenopathy. Histopathology, immunohistochemical testing and clinico-pathological correlation confirmed the diagnosis of Castleman's disease. The patients were successfully treated with surgery and/or rituximab. They were symptoms free in the subsequent follow-up visits. A brief review of the literature is also provided.
引用
收藏
页数:5
相关论文
共 15 条
  • [1] Human herpesvirus 8-positive Castleman disease in human immunodeficiency virus-infected patients: The impact of highly active antiretroviral therapy
    Aaron, L
    Lidove, O
    Yousry, C
    Roudiere, L
    Dupont, B
    Viard, JP
    [J]. CLINICAL INFECTIOUS DISEASES, 2002, 35 (07) : 880 - 882
  • [2] Ascoli V, 2001, J PATHOL, V193, P200
  • [3] Treatment of Unicentric Castleman Disease With Neoadjuvant Rituximab
    Bandera, Bradley
    Ainsworth, Craig
    Shikle, James
    Rupard, Erik
    Roach, Michael
    [J]. CHEST, 2010, 138 (05) : 1239 - 1241
  • [4] de Vries IAC., 2010, RADIAT ONCOL, V5, P1
  • [5] Overview of Castleman disease
    Dispenzieri, Angela
    Fajgenbaum, David C.
    [J]. BLOOD, 2020, 135 (16) : 1353 - 1364
  • [6] Castelman's disease of the neck: a case report and literature review
    El Korbi, Amel
    Jellali, Sondes
    Jguiri, Mahbouba
    Bellalah, Ahlem
    Ferjaoui, Mehdi
    Bouatay, Rachida
    Kolsi, Naourez
    Harrathi, Khaled
    Koubaa, Jamel
    [J]. PAN AFRICAN MEDICAL JOURNAL, 2020, 37 : 369
  • [7] Determining Chemotherapy Tolerance in Older Patients With Cancer
    Kim, Jerome
    Hurria, Arti
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2013, 11 (12): : 1494 - 1502
  • [8] The management of Castleman disease
    Lomas, Oliver C.
    Streetly, Matthew
    Pratt, Guy
    Cavet, Jim
    Royston, Daniel
    Schey, Stephen
    Ramasamy, Karthik
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2021, 195 (03) : 328 - 337
  • [9] Intensity modulated radiation therapy (IMRT) for the treatment of unicentric Castlemans disease: a case report and review of the use of radiotherapy in the literature
    Matthiesen, Chance
    Ramgopol, Rajeev
    Seavey, Jonathan
    Ahmad, Salahuddin
    Herman, Terence
    [J]. RADIOLOGY AND ONCOLOGY, 2012, 46 (03) : 265 - 270
  • [10] The role of surgical resection in Unicentric Castleman's disease: a systematic review
    Mitsos, Sofoklis
    Stamatopoulos, Alexandros
    Patrini, Davide
    George, Robert S.
    Lawrence, David R.
    Panagiotopoulos, Nikolaos
    [J]. ADVANCES IN RESPIRATORY MEDICINE, 2018, 86 (01) : 36 - 43